🇺🇸 FDA
Patent

US 9175058

Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases

granted A61KA61K38/17A61P

Quick answer

US patent 9175058 (Soluble immune response suppressor polypeptides and treatment of multiple sclerosis and other autoimmune diseases) held by The Board of Regents of the University of Texas System expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K38/17, A61P, A61P37/00